Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Terns Pharmaceuticals Inc (NQ: TERN )

9.100 +0.290 (+3.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 166,026
Open 8.920
Bid (Size) 8.520 (1)
Ask (Size) 9.500 (1)
Prev. Close 8.810
Today's Range 8.565 - 9.200
52wk Range 1.450 - 11.44
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
 
Via Benzinga

Performance

YTD
+3.64%
+3.64%
1 Month
-14.95%
-14.95%
3 Month
+6.81%
+6.81%
6 Month
+60.78%
+60.78%
1 Year
+197.39%
+197.39%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2023
Via Benzinga
Terns Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2023 Oncology Conference
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Terns Pharmaceuticals to Present at B. Riley Securities’ 3rd Annual Oncology Conference
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Terns Pharmaceuticals to Highlight 2023 Priorities and Clinical Milestones at the 41st Annual J.P. Morgan Healthcare Conference
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
Tesla To $250? Here Are 10 Other Price Target Changes For Thursday
Via Benzinga
$2.4 Million Bet On Duolingo? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
$5.5 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
BlackBerry, Calavo Growers And Some Other Big Stocks Moving Lower On Wednesday
Via Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Core Scientific Shares Are Trading Lower By Around 32%; Here Are 26 Stocks Moving Premarket
Via Benzinga
Terns Announces Pricing of $75 Million Public Offering
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
Terns Announces Proposed Public Offering
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Terns Pharmaceuticals to Present at the 2022 JMP Securities Hematology and Oncology Summit
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
Terns Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Highlights
From Terns Pharmaceuticals, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.